Effects of BTK inhibitor on gefitinib-resistance non-small cell lung cancer

被引：0
|
作者：
Hong, T-M. [1 ]
Fang, Y-T. [1 ]
Chen, Y-L. [1 ]
机构：
[1] Natl Cheng Kung Univ, Tainan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
32P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer
    Lu, Xiangdong
    Zhang, Yao
    Pan, Yukai
    Cao, Minmin
    Zhou, Xie
    Zhang, Tingrong
    ONCOLOGY LETTERS, 2021, 21 (01) : 1 - 8
  • [12] Gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2019, 1744 (1) : 138 - 138
  • [13] Amphiregulin induces resistance to gefitinib in non-small cell lung cancer cell lines
    Busser, Benoit
    Lucie, Sancey
    Marie, Favrot
    Luc, Coll Jean
    Amandine, Hurbin
    BULLETIN DU CANCER, 2009, 96 : S55 - S55
  • [14] Gefitinib therapy for non-small cell lung cancer
    Birnbaum A.
    Ready N.
    Current Treatment Options in Oncology, 2005, 6 (1) : 75 - 81
  • [15] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [16] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [17] LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621
    Chen, Z. -Y.
    Liu, H. -Y.
    Jiang, N.
    Yuan, J. -M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9939 - 9946
  • [18] Antiproliferative Effects of Combined Tamoxifen and Gefitinib in Non-Small Cell Lung Cancer
    Hua Shen
    Yuan Yuan
    Wen Gao
    Jin Sun
    Shu, Yong-qian
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 327 - 327
  • [19] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    Cui, F.
    Wang, W.
    Wu, D.
    He, X.
    Wu, J.
    Wang, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 722 - 727
  • [20] Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1850 (1) : 131 - 131
12345